Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C25H27N9 |
| Molecular Weight | 453.5422 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
| Stereo Comments | Substituted ring |
SHOW SMILES / InChI
SMILES
CN1N=NC(=N1)C2=CC3=C(C=C2)C4=C(N3)N=C(CC5=CC=CC=C5)N=C4N[C@H]6CC[C@H](N)CC6
InChI
InChIKey=AZXXGVPWWKWGAE-IYARVYRRSA-N
InChI=1S/C25H27N9/c1-34-32-23(31-33-34)16-7-12-19-20(14-16)28-25-22(19)24(27-18-10-8-17(26)9-11-18)29-21(30-25)13-15-5-3-2-4-6-15/h2-7,12,14,17-18H,8-11,13,26H2,1H3,(H2,27,28,29,30)/t17-,18-
| Molecular Formula | C25H27N9 |
| Molecular Weight | 453.5422 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/25237102Curator's Comment: description was created based on several sources, including
http://www.google.com/patents/WO2013110198A1 | https://www.ncbi.nlm.nih.gov/pubmed/28330619 | https://www.ncbi.nlm.nih.gov/pubmed/27337543 | https://clinicaltrials.gov/ct2/show/study/NCT02668315
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25237102
Curator's Comment: description was created based on several sources, including
http://www.google.com/patents/WO2013110198A1 | https://www.ncbi.nlm.nih.gov/pubmed/28330619 | https://www.ncbi.nlm.nih.gov/pubmed/27337543 | https://clinicaltrials.gov/ct2/show/study/NCT02668315
UM171 is a potent agonist of human hematopoietic stem cell renewal, independently of AhR suppression. UM171 act differently than other small molecule stimulators of hematopoiesis, such as the aryl hydrocarbon receptor (AhR) antagonist StemRegenin 1 (SR1). Addition of UM171 to cultures containing SR1 and cytokines further enhances the ex vivo expansion of normal HSCs, including CD34+ cells.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: WP2849 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27337543 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25237102
CD34+ cells isolated from cord blood (CB) were cultured in a fed-batch (FB) system for 12 days in the presence of cytokines and UM171 [35 nM], SR1 [750 nM] or the combination of both UM171 [35 nM] and SR1 [500 nM].
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 22:36:01 GMT 2025
by
admin
on
Tue Apr 01 22:36:01 GMT 2025
|
| Record UNII |
8XZ4J0KS9C
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000009941
Created by
admin on Tue Apr 01 22:36:01 GMT 2025 , Edited by admin on Tue Apr 01 22:36:01 GMT 2025
|
PRIMARY | |||
|
1448724-09-1
Created by
admin on Tue Apr 01 22:36:01 GMT 2025 , Edited by admin on Tue Apr 01 22:36:01 GMT 2025
|
PRIMARY | |||
|
8XZ4J0KS9C
Created by
admin on Tue Apr 01 22:36:01 GMT 2025 , Edited by admin on Tue Apr 01 22:36:01 GMT 2025
|
PRIMARY | |||
|
DTXSID201108994
Created by
admin on Tue Apr 01 22:36:01 GMT 2025 , Edited by admin on Tue Apr 01 22:36:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
UM171 could significantly expand human cord blood HSCs ex vivo with the help of their newly developed automated and continuous medium delivery system
|